This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
broker-rating: Archive
Brokers Suggest Investing in Intuitive Surgical (ISRG): Read This Before Placing a Bet
by Zacks Equity Research
The average brokerage recommendation (ABR) for Intuitive Surgical (ISRG) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
ISRGPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is Energy Fuels (UUUU) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Energy Fuels (UUUU) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
UUUUNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Bulls Look Optimistic About Disney (DIS): Should You Buy?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Disney (DIS) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
DISPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Brokers Suggest Investing in Devon Energy (DVN): Read This Before Placing a Bet
by Zacks Equity Research
The average brokerage recommendation (ABR) for Devon Energy (DVN) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
DVNPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Analysts See Merck (MRK) as a Buy: Should You Invest?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Merck (MRK). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
MRKNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Brokers Suggest Investing in High Tide (HITI): Read This Before Placing a Bet
by Zacks Equity Research
The average brokerage recommendation (ABR) for High Tide (HITI) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
HITINegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Analysts Look Bullish on Adma Biologics (ADMA): Should You Buy?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Adma Biologics (ADMA) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
ADMANegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Analysts Think QuickLogic (QUIK) Is a Good Investment: Is It?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), QuickLogic (QUIK) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
QUIKPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is Reddit Inc. (RDDT) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Reddit Inc. (RDDT) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
RDDTPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Brokers Suggest Investing in Toyota Motor (TM): Read This Before Placing a Bet
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Toyota Motor (TM). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
TMPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Brokers Suggest Investing in Lithium Americas Corp. (LAC): Read This Before Placing a Bet
by Zacks Equity Research
The average brokerage recommendation (ABR) for Lithium Americas Corp. (LAC) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
LACNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is DraftKings (DKNG) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in DraftKings (DKNG). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
DKNGNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Brokers Suggest Investing in Salesforce.com (CRM): Read This Before Placing a Bet
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Salesforce.com (CRM) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
CRMNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is OneSpan (OSPN) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), OneSpan (OSPN) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
OSPNNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Analysts Think PDD Holdings Inc. Sponsored ADR (PDD) Is a Good Investment: Is It?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in PDD Holdings Inc. Sponsored ADR (PDD). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
PDDPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Skechers (SKX) Is Considered a Good Investment by Brokers: Is That True?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Skechers (SKX) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
SKXNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is It Worth Investing in Nextracker (NXT) Based on Wall Street's Bullish Views?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Nextracker (NXT) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
NXTPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Analysts See Baidu Inc. (BIDU) as a Buy: Should You Invest?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Baidu Inc. (BIDU) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
BIDUPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Bulls Look Optimistic About Bit Digital (BTBT): Should You Buy?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Bit Digital (BTBT) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
BTBTNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Analysts See Enterprise Products (EPD) as a Buy: Should You Invest?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Enterprise Products (EPD) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
EPDNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Brokers Suggest Investing in TJX (TJX): Read This Before Placing a Bet
by Zacks Equity Research
The average brokerage recommendation (ABR) for TJX (TJX) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
TJXPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Analysts Think Royal Caribbean (RCL) Is a Good Investment: Is It?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Royal Caribbean (RCL) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
RCLPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is It Worth Investing in NextEra (NEE) Based on Wall Street's Bullish Views?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), NextEra (NEE) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
NEENegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Uber (UBER) Is Considered a Good Investment by Brokers: Is That True?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Uber (UBER) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
UBERNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is PulteGroup (PHM) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), PulteGroup (PHM) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
PHMPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth